1 year return (CAGR)
-60.10%
Evogene Exchange (NASDAQ, USD)
EVGN
0.49
+0.01 (+3.08%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-59.59%
5 year return (CAGR)
-56.67%
10 year return (CAGR)
-38.61%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
7.82M
Price/Sales
5.98
Ent value
6.14M
Price/Book
1.36
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-23.06%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-33.52%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.48 |
| Daily high | 0.51 |
| Daily low | 0.47 |
| Daily Volume | 113K |
| All-time high | 362.00 |
| 1y analyst estimate | 2.15 |
| Beta | 0.70 |
| EPS (TTM) | -0.74 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| EVGN | S&P500 | |
| Current price drop from All-time high | -99.86% | -2.19% |
| Highest price drop | -99.89% | -56.47% |
| Date of highest drop | 26 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -88.58% | -10.68% |
| Avg time to new high | 390 days | 12 days |
| Max time to new high | 3110 days | 1805 days |
News
